期刊文献+

超敏C反应蛋白在冠心病患者中的表达 被引量:4

The Expression of High Sensitivity C-reactive Protein in Patients with Coronary Heart Disease
下载PDF
导出
摘要 目的探讨超敏C反应蛋白(hs-CRP)在冠心病患者中的表达.方法对327例患者行冠状动脉造影并采用免疫散射比浊法测定血清中超敏C反应蛋白的含量,根据冠状动脉造影狭窄情况分为冠状动脉正常组39例,冠状动脉粥样硬化组91例,单支病变组95例,多支病变组102例,其中后两组患者诊断为冠心病.在冠心病组又分为稳定型心绞痛组53例,不稳定型心绞痛组65例,急性心肌梗死组79例.结果血清hs-CRP水平在单支病变组与多支病变组、单支病变组与粥样硬化组、稳定型心绞痛组与不稳定型心绞痛组、不稳定型心绞痛组与急性心肌梗死组比较差异有统计学意义(P<0.05),正常组与粥样硬化组比较差异无统计学意义(P>0.05).结论超敏C反应蛋白在冠心病的发生、发展和预后过程中起重要作用,可作为反映冠状动脉粥样硬化程度的敏感指标. Objective To discuss the expression of high-sensitivity C-reactive protein(hs-CRP)in patients with coronary heart disease.Methods Totally 327 patients who had undergo coronary angioplasty and investigated the level of hs-CRP by immune scatter turbidimetry were divided into the normal vessel group(n=39),coronary atherosclerosis group(n=91),single vessel disease group(n=95),and multiple vessel disease group(n=102),the latter two groups were diagnosed with coronary heart disease(CHD),which were divided into the stable angina pectoris group(n=53),unstable angina pectoris group(n=65)and acute myocardial infarction group(n=79).Results There were significant differences between single vessel disease group and multiple vessel disease group,single vessel disease group and atherosclerosis group,stable angina pectoris group and unstable angina pectoris group,unstable angina group and acute myocardial infarction group.But there was no significant difference between normal vessel group and coronary atherosclerosis group.Conclusion Hs-CRP plays an important role in the pathogenesis,development and prognosis of coronary heart disease,which would be a sensitive indicators for assessing coronary atherosclerosis degree.
作者 杞虹 李建美
出处 《昆明医学院学报》 2010年第11期148-150,共3页 Journal of Kunming Medical College
关键词 超敏C反应蛋白 冠心病 表达 High-sensitivity C-reactive protein Coronary heart disease Expresion
  • 相关文献

参考文献7

  • 1REISS A B,GLASS A D. Atherosclerosis:immune and inflammatory aspects [J]. J Investig Med,2006,54(3 ) : 123- 131.
  • 2LOWE G D. The association between elevated levels of inflammation biomarkers and coronary artery disease and death[J]. CMA J,2006,174(4) :479 - 480.
  • 3DANESH J, WHEELER J G, HIRSCHFIELD G M, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J]. N Engl J Med,2004,350:387 - 1397.
  • 4PAUL M,CHARIES H,JULIE E,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women [J ]. N Engl J Med, 2000,343 (7):512.
  • 5黄广勇,卢才义,李义波,吴兴利.高敏C反应蛋白与老年冠心病患者冠状动脉病变及对心脏事件的预测作用[J].中华老年心脑血管病杂志,2008,10(10):737-739. 被引量:12
  • 6CHRISMS K,PAUL D T. The effect of physical activity on serum C-reactive protein and inflammatory markers [J]. J Am Coll Cardiol,2005,45(10) : 1563.
  • 7VERMA S, LI S H, BADIWALMV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of c-reactive protein [J ]. Circulation, 2002,105 : 1890 - 1896.

二级参考文献6

  • 1黄广勇,卢才义,张玉霄,吴兴利,薛桥,晏沐阳.冠心病患者冠状动脉重构的影响因素与病变特征[J].中华老年心脑血管病杂志,2006,8(3):162-164. 被引量:4
  • 2Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med, 2005,352 : 1685-1695.
  • 3Pearson TA,Mensah GA,Alexander RW,et al. Markers of inflammation and cardiovascular disease--application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003, 107: 499-511.
  • 4Smith SC, Dove JT,Jacobs AK,et al. ACC/AHA guidelines for percutaneous coronary intervention. J Am Coll Cardiol, 2001,37:2215-2239.
  • 5Danesh J, Wheeler J, Hirschfield GM, et al. C-reaction protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med, 2004, 350: 1387- 1397.
  • 6Sattar N, Murray H, McConnachie A, et al. C-Reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk(PROSPER). Circulation, 2007,115 : 981-989.

共引文献11

同被引文献50

  • 1潘永瑜,刘芳,刘蓓菁.老年冠心病患者超敏C-反应蛋白水平与冠状动脉粥样硬化易损斑块检出情况分析[J].中国全科医学,2009,12(13):1209-1210. 被引量:33
  • 2吴惠玲,何国祥,刘建平,冉擘力,李永华,仝识非,姚青,唐波.血浆超敏C反应蛋白水平与冠心病及粥样斑块的关系[J].临床心血管病杂志,2006,22(7):405-407. 被引量:30
  • 3马梅,齐新,何丽华,张东玲,孟东,刘克强.血清超敏C反应蛋白对冠心病患者诊断的临床意义[J].中国心血管病研究,2007,5(7):527-530. 被引量:13
  • 4Lim SY. Role of statins in coronary artery disease[J]. Chonnam Med J,2013,49(1) :1-6.
  • 5O'Shea P,Daly R,Kasim S,et al. B-type natriuretic pep- tide in the cardiology department[J]. Ir Med J, 2012, 105(10) :341-343.
  • 6Giannopoulos G, Deftereos S, Panagopoulou V, et al. Copeptin as a biomarker in cardiac disease[J]. Curr Top Med Chem,2013,13(2) :231-240.
  • 7Barac A, Wang H, Shara NM, et al. C-reactive pro- tein, fibrinogen, and incident heart failure in the Strong Heart Study population[J]. J Clin Hypertens (Green- wich) ,2013,15(4) :299.
  • 8Palazzuoli A, Deckers J, Calabr6 A, et al. Brain natn- uretic peptide and other risk markers for outcome as- sessment in patients with non-ST-elevation coronary syndromes and preserved systolic function[J]. Am J Cardiol,2006,98(10) :1322-1328.
  • 9Scirica BM, Cannon CP, Sabatine MS,et al. Concentra- tions of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascu- lar death[J]. Clin Chem,2009,55(2) :265-273.
  • 10Li JJ ,Yang P, Liu J, et al. Impact of 10 mg rosuvastatin daily m alternate-day on lipid profile and inflammatory markers [ J ]. Clin Chim Acta,2012,413 ( 1 - 2 ) : 139 - 142.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部